1830 — Perfect Medical Health Management Cashflow Statement
0.000.00%
- HK$2.73bn
- HK$2.48bn
- HK$1.39bn
- 94
- 70
- 57
- 88
Annual cashflow statement for Perfect Medical Health Management, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 451 | 358 | 378 | 391 | 384 |
Depreciation | |||||
Non-Cash Items | 7.86 | 6.64 | 19.4 | 6.55 | 0.306 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 31.1 | 61.8 | -103 | -61 | -88.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 644 | 598 | 514 | 561 | 497 |
Capital Expenditures | -96.4 | -78.2 | -145 | -26.7 | -54.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 23.4 | -220 | 155 | -194 | 217 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -73.1 | -298 | 10.1 | -221 | 163 |
Financing Cash Flow Items | -11.9 | -13.1 | -16.1 | -12.5 | -6.53 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -330 | -394 | -566 | -335 | -521 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 225 | -73.8 | -45.2 | -5.41 | 128 |